Department of Surgery, Klinikum Rechts der Isar, Technische Universität München, Ismaninger Str, 22, Munich, D-81675, Germany.
BMC Gastroenterol. 2013 Jan 16;13:14. doi: 10.1186/1471-230X-13-14.
The glycoprotein MFG-E8 mediates phagocytic clearance of apoptotic cells and influences the pathogenesis and progression of inflammatory diseases. MFG-E8 was shown to attenuate the progression of inflammation and to improve survival in septic rats. Accumulating evidence suggests an immunomodulatory link between MFG-E8 and the pro-inflammatory chemokine fractalkine, which may determine the severity of pain, fibrosis, and inflammation in chronic pancreatitis (CP).
The expression and localization of MFG-E8 was investigated in CP (n=62), and normal pancreas (NP; n=34) by QRT-PCR, Western-blot and immunohistochemistry analyses. Results were correlated with mRNA expression of fractalkine, CX3CR1, and with the presence and degree of pain and fibrosis. Human pancreatic stellate cells (hPSCs) were isolated from CP tissues and evaluated for MFG-E8 mRNA expression after fractalkine stimulation.
MFG-E8-mRNA was significantly overexpressed in CP and isolated hPSCs when compared to NP. Western-blot and immunohistochemistry analysis confirmed accumulation of MFG-E8 in CP, with noticeably increased MFG-E8 immunoreactivity in tubular complexes. MFG-E8 expression correlated significantly with fractalkine expression, severe fibrosis, and the presence of pain in CP patients. Stimulation of hPSCs with fractalkine led to a significant increase in MFG-E8 expression.
In the present study, we demonstrated for the first time that MFG-E8 is significantly up-regulated in CP patients and together with fractalkine correlated noticeably with severe fibrosis and the presence of pain. hPSCs overexpress MFG-E8 upon fractalkine stimulation in vitro, which underlines the suggested immunmodulatory link in CP and may be a key mechanism in CP fibrogenesis and pain generation. Taken together, these novel findings suggest that MFG-E8 blockade may be a promising tool for future immunotherapy in CP to attenuate both fibrosis and pain sensation.
糖蛋白 MFG-E8 介导凋亡细胞的吞噬清除,并影响炎症性疾病的发病机制和进展。研究表明,MFG-E8 可减轻炎症的进展并提高脓毒症大鼠的存活率。越来越多的证据表明,MFG-E8 与促炎趋化因子 fractalkine 之间存在免疫调节联系,这可能决定慢性胰腺炎 (CP) 中疼痛、纤维化和炎症的严重程度。
通过 QRT-PCR、Western-blot 和免疫组织化学分析,研究 CP(n=62)和正常胰腺(NP;n=34)中 MFG-E8 的表达和定位。结果与 fractalkine、CX3CR1 的 mRNA 表达以及疼痛和纤维化的存在和程度相关。从 CP 组织中分离出人胰腺星状细胞 (hPSC),并在 fractalkine 刺激后评估 MFG-E8 mRNA 表达。
与 NP 相比,CP 和分离的 hPSC 中 MFG-E8-mRNA 明显过表达。Western-blot 和免疫组织化学分析证实 CP 中 MFG-E8 积聚,管状复合物中 MFG-E8 免疫反应性明显增加。CP 患者中 MFG-E8 表达与 fractalkine 表达、严重纤维化和疼痛存在显著相关。 fractalkine 刺激 hPSC 导致 MFG-E8 表达显著增加。
在本研究中,我们首次证明 MFG-E8 在 CP 患者中显著上调,与 fractalkine 一起与严重纤维化和疼痛存在显著相关。体外 fractalkine 刺激 hPSC 过度表达 MFG-E8,这强调了 CP 中建议的免疫调节联系,可能是 CP 纤维化和疼痛产生的关键机制。综上所述,这些新发现表明,MFG-E8 阻断可能是 CP 未来免疫治疗中减轻纤维化和疼痛感觉的有前途的工具。